GLOBALT Investments LLC GA grew its stake in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 2.2% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 5,925 shares of the financial services provider’s stock after purchasing an additional 125 shares during the period. GLOBALT Investments LLC GA’s holdings in CME Group were worth $1,307,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Capital International Investors boosted its position in CME Group by 24.1% during the 1st quarter. Capital International Investors now owns 15,809,175 shares of the financial services provider’s stock valued at $3,403,557,000 after acquiring an additional 3,069,806 shares in the last quarter. PineStone Asset Management Inc. boosted its position in shares of CME Group by 137.6% during the second quarter. PineStone Asset Management Inc. now owns 2,260,644 shares of the financial services provider’s stock valued at $444,443,000 after purchasing an additional 1,309,097 shares in the last quarter. Assenagon Asset Management S.A. grew its stake in CME Group by 577.9% in the second quarter. Assenagon Asset Management S.A. now owns 645,330 shares of the financial services provider’s stock worth $126,872,000 after purchasing an additional 550,133 shares during the period. Ameriprise Financial Inc. raised its holdings in CME Group by 11.3% in the second quarter. Ameriprise Financial Inc. now owns 5,283,196 shares of the financial services provider’s stock worth $1,038,676,000 after purchasing an additional 537,758 shares in the last quarter. Finally, International Assets Investment Management LLC raised its holdings in CME Group by 21,465.5% in the third quarter. International Assets Investment Management LLC now owns 485,871 shares of the financial services provider’s stock worth $1,072,070,000 after purchasing an additional 483,618 shares in the last quarter. Hedge funds and other institutional investors own 87.75% of the company’s stock.
Insider Buying and Selling at CME Group
In other CME Group news, insider Timothy Francis Mccourt sold 1,374 shares of the stock in a transaction that occurred on Monday, October 28th. The shares were sold at an average price of $227.12, for a total value of $312,062.88. Following the transaction, the insider now directly owns 7,275 shares in the company, valued at approximately $1,652,298. This trade represents a 15.89 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Sunil Cutinho sold 4,500 shares of the business’s stock in a transaction on Wednesday, October 30th. The shares were sold at an average price of $226.64, for a total transaction of $1,019,880.00. Following the sale, the insider now directly owns 27,053 shares of the company’s stock, valued at approximately $6,131,291.92. The trade was a 14.26 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 15,621 shares of company stock valued at $3,441,063. 0.30% of the stock is owned by company insiders.
CME Group Stock Performance
CME Group (NASDAQ:CME – Get Free Report) last posted its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, topping analysts’ consensus estimates of $2.65 by $0.03. The business had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.59 billion. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The firm’s revenue was up 18.4% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.25 EPS. As a group, equities research analysts expect that CME Group Inc. will post 10.22 earnings per share for the current year.
CME Group Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Monday, December 9th will be given a dividend of $1.15 per share. This represents a $4.60 dividend on an annualized basis and a yield of 2.02%. The ex-dividend date is Monday, December 9th. CME Group’s dividend payout ratio (DPR) is presently 48.37%.
Analysts Set New Price Targets
A number of research firms have recently weighed in on CME. JPMorgan Chase & Co. upped their target price on shares of CME Group from $187.00 to $191.00 and gave the stock an “underweight” rating in a research report on Thursday, July 25th. Deutsche Bank Aktiengesellschaft cut their price objective on shares of CME Group from $227.00 to $226.00 and set a “hold” rating on the stock in a report on Monday, November 11th. Redburn Atlantic lowered shares of CME Group from a “buy” rating to a “neutral” rating and set a $244.00 target price for the company. in a report on Tuesday, October 8th. The Goldman Sachs Group upped their price target on CME Group from $195.00 to $198.00 and gave the stock a “sell” rating in a research note on Thursday, October 3rd. Finally, Royal Bank of Canada reiterated a “sector perform” rating and set a $235.00 price objective on shares of CME Group in a research note on Thursday, October 24th. Four investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $224.47.
Read Our Latest Stock Report on CME
CME Group Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Featured Stories
- Five stocks we like better than CME Group
- CD Calculator: Certificate of Deposit Calculator
- Is Monolithic Power Systems a Screaming Buy After Near 40% Drop?
- High Flyers: 3 Natural Gas Stocks for March 2022
- Applied Materials Market Capitulates: Now is the Time to Buy
- Short Selling: How to Short a Stock
- 3 Ultra-High Dividend Yield Stocks for the New Year
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.